Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* survey of Belgian specialists *THESIS: treatment of hypothyroidism in Europe by specialists: an international survey ...

Abstract Background Hypothyroidism is a topic that continues to provoke debate and controversy with regards to specific indications, type of thyroid hormone substitution and efficacy. We investigated the use of thyroid hormones in clinical practice in Belgium, a country where currently only levothyroxine (LT4) tablet formulations are available. Method Members of the Belgian Endocrine Society were invited to respond to an online questionnaire. Results were compared with those from other THESIS surveys. Results Eighty (50%) of the invited 160 individuals, completed the questionnaire. LT4 was the... Mehr ...

Verfasser: Burlacu, Maria-Cristina
Attanasio, Roberto
Hegedüs, Laszlo
Nagy, Endre V.
Papini, Enrico
Perros, Petros
Sawadogo, Kiswendsida
Bex, Marie
Corvilain, Bernard
Daumerie, Chantal
Decallonne, Brigitte
Gruson, Damien
Lapauw, Bruno
Reyes, Rodrigo Moreno
Petrossians, Patrick
Poppe, Kris
Van den Bruel, Annick
Unuane, David
Dokumenttyp: Datenquelle
Erscheinungsdatum: 2022
Verlag/Hrsg.: figshare
Schlagwörter: Medicine / Genetics / FOS: Biological sciences / Physiology / Pharmacology / Biotechnology / 39999 Chemical Sciences not elsewhere classified / FOS: Chemical sciences / Sociology / FOS: Sociology / 19999 Mathematical Sciences not elsewhere classified / FOS: Mathematics / Cancer
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-28885389
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dx.doi.org/10.6084/m9.figshare.c.5878454

Abstract Background Hypothyroidism is a topic that continues to provoke debate and controversy with regards to specific indications, type of thyroid hormone substitution and efficacy. We investigated the use of thyroid hormones in clinical practice in Belgium, a country where currently only levothyroxine (LT4) tablet formulations are available. Method Members of the Belgian Endocrine Society were invited to respond to an online questionnaire. Results were compared with those from other THESIS surveys. Results Eighty (50%) of the invited 160 individuals, completed the questionnaire. LT4 was the first treatment of choice for all respondents. As secondary choice, some also prescribed liothyronine (LT3) and LT4 + LT3 combinations (2 and 7 respondents, respectively). Besides hypothyroidism, 34 and 50% of respondents used thyroid hormones for infertile euthyroid TPOAb positive women and the treatment of a growing non-toxic goiter, respectively. Had alternative formulations of LT4 to tablets been available (soft ...